TEAM ARCHIVE / 2013-07-15

Historical ANVISA operating-authorization milestone

Historical report translated and adapted from the team’s archive. Events, company activities and regulatory references describe the original period.

July 15, 2013. The company at the time reported federal ANVISA approval of its quality manual and good manufacturing practices, while awaiting certification and registration of several products for its own facilities.

Previously dependent on partners for commercialization and public tenders, the company described this as an important step toward manufacturing and selling its own products. It was also arranging an export partnership in California, with a contract expected the following week. The archived announcement reported FDA status for CHROMA and anticipated broader activity in Latin America. These are historical statements about the company and products at that time, rather than current EVOptica authorizations.

THE NEXT CHAPTER IN OPHTHALMIC TECHNOLOGY

Find the right instrument
for your practice.

Contact sales ↗